We demonstrate that COVID-19 patients possess subtly elevated TICAM-1 expression (Figs. 10A and 12H) and NF-kappaB signaling in the hippocampus (Fig. 10C), the latter of which is the direct effect of the TLR-TICAM-1 signaling cascade. The gene discussed is TICAM1; the disease is COVID-19.